Related Experiment Video
Updated: Jan 3, 2026
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Xpert MTB/RIF Ultra: Optimal procedures for the detection of Mycobacterium tuberculosis in cerebrospinal fluid
Jerome H Chin1, Willy Ssengooba2, Scott Grossman1
1Department of Neurology, NYU Langone Health, New York, NY, USA.
Abstract:
Tuberculosis is the leading infectious cause of death globally and extra-pulmonary disease occurs in 15% of incident cases annually. Tuberculous meningitis (TBM) is arguably the most lethal form of tuberculosis and requires prompt diagnosis and initiation of treatment to prevent death and serious neurological disability. The development of rapid diagnostic tests using polymerase chain reaction (PCR) technology for the detection of Mycobacterium tuberculosis (MTB), including the World Health Organization (WHO) - endorsed Xpert MTB/RIF Ultra assay, has allowed earlier definite diagnosis of TBM than conventional culture methods which usually take two weeks or longer for positive identification of MTB. Detection of MTB in cerebrospinal fluid (CSF) using PCR assays requires special attention to the collection, handling, and processing of CSF. Herein we present best practices guidance to maximize the detection rate of MTB in CSF using Xpert MTB/RIF Ultra.
Insights
Tuberculous meningitis (TBM) diagnosis is improved by rapid polymerase chain reaction (PCR) tests like Xpert MTB/RIF Ultra. Following best practices for cerebrospinal fluid (CSF) sample handling maximizes detection of Mycobacterium tuberculosis (MTB).
Area of Science:
- Infectious Diseases
- Microbiology
- Neurology
Background:
- Tuberculosis remains a leading global infectious cause of mortality.
- Tuberculous meningitis (TBM) is the most lethal form of tuberculosis, necessitating rapid diagnosis and treatment to prevent mortality and neurological sequelae.
- Conventional culture methods for Mycobacterium tuberculosis (MTB) identification in cerebrospinal fluid (CSF) are time-consuming, often exceeding two weeks.
Discussion:
- Polymerase chain reaction (PCR) technologies, particularly the Xpert MTB/RIF Ultra assay, enable earlier and more definitive TBM diagnosis.
- Accurate detection of MTB in CSF via PCR requires meticulous attention to sample collection, handling, and processing protocols.
- Optimized CSF sample management is crucial for maximizing the sensitivity of molecular diagnostic assays for TBM.
Key Insights:
- The Xpert MTB/RIF Ultra assay significantly reduces the time to diagnosis for TBM compared to traditional methods.
- Standardized best practices in CSF specimen handling are essential for enhancing the diagnostic yield of PCR-based MTB detection.
- Early and accurate TBM diagnosis facilitates timely therapeutic intervention, improving patient outcomes.
Outlook:
- Further refinement of molecular diagnostic techniques and standardized protocols will improve TBM detection rates globally.
- Wider implementation of rapid molecular assays and adherence to best practices can reduce TBM-related morbidity and mortality.
- Continued research into optimizing sample processing for extra-pulmonary tuberculosis diagnostics is warranted.
